Bust in Oldham: Huge Seizure of Illegal E-cigarettes and Cigarettes

Regulations by 2FIRSTS.ai
Jan.18.2024
Bust in Oldham: Huge Seizure of Illegal E-cigarettes and Cigarettes
Greater Manchester Police confiscate large quantities of illegal e-cigarettes and cigarettes in an operation in Oldham.

According to a report by the British media outlet Chronicle on January 17th, a significant amount of illegal e-cigarettes and cigarettes were seized by local police in Oldham as part of the "Operation Avro" enforcement action conducted by the Greater Manchester Police.

 

GMP Oldham Central's Facebook page has posted a message stating that their community team carried out illegal e-cigarette and cigarette inspections at six locations during the "Operation Avow" on January 16th. Out of these, four locations had items confiscated, including 1313 e-cigarettes and 310 packs of illegal cigarettes, with a total value of £20,411.

 

The community prevention team's work has been highly appreciated. The Oldham Chronicle is calling on and welcoming residents to participate and support quality community news coverage, by providing financial support of £3 per month to the Oldham Chronicle, so that they can continue to provide improved news services in the future.

 

The recent successful law enforcement operation clearly demonstrates the UK police's strong stance against illegal tobacco products, effectively suppressing the market for illegal e-cigarettes and cigarettes. The relentless efforts of the community team have set an example for community safety and the rule of law environment.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Make Your Brand Understood by the People Who Matter
Make Your Brand Understood by the People Who Matter
Feb.02
MEPs seek Commission answers over EU trade officials’ contacts with PMI
MEPs seek Commission answers over EU trade officials’ contacts with PMI
POLITICO reports that five members of the European Parliament’s health committee want to invite the European Commission to answer questions about its contacts with Philip Morris International (PMI), following a POLITICO and The Examination investigation into extensive meetings between EU trade officials and tobacco lobbyists.
Jan.15 by 2FIRSTS.ai
U.S. Fifth Circuit judges question FDA’s claim it has no de facto ban on flavored refillable e-cigarettes
U.S. Fifth Circuit judges question FDA’s claim it has no de facto ban on flavored refillable e-cigarettes
Law360 reports that a Fifth Circuit panel expressed skepticism about the FDA’s claim that it has no de facto ban on flavored refillable e-cigarette products, noting that only six applications had been approved out of hundreds of thousands and that near-100% denials look like a ban.
Jan.07 by 2FIRSTS.ai
Polish Government to Amend E-Cigarette Definitions, Applying  PLN 40 Excise Tax to Magnetic-attachment Devices
Polish Government to Amend E-Cigarette Definitions, Applying PLN 40 Excise Tax to Magnetic-attachment Devices
Poland plans to amend its excise tax regulations on e-cigarettes to address a loophole created by the emergence of electromagnetic iMagnetic-attachment devices in 2025. Under the proposal, products incorporating ferromagnetic components will be classified as e-cigarettes and subject to an excise tax of PLN 40 (about USD 11.2) per unit. The revised rules are expected to take effect 14 days after promulgation.
Dec.26 by 2FIRSTS.ai
Mexico’s ENCODAT 2025 finds smoking rate falls as vaping rises
Mexico’s ENCODAT 2025 finds smoking rate falls as vaping rises
Results from Mexico’s ENCODAT 2025 indicate a structural shift in tobacco and nicotine use: past-month combustible tobacco use among the general population (ages 12–65) declined to 15.1%, down from 17.6% in 2016, while past-month e-cigarette use increased to 2.6%, up from 1.1%.
Dec.25 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11